You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

McKesson
Merck
Mallinckrodt
Moodys
Johnson and Johnson
McKinsey

Last Updated: August 7, 2020

DrugPatentWatch Database Preview

Litigation Details for Vanda Pharmaceuticals Inc. v. Taro Pharmaceuticals USA, Inc. (D. Del. 2015)

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in Vanda Pharmaceuticals Inc. v. Taro Pharmaceuticals USA, Inc.
The small molecule drug covered by the patents cited in this case is   Start Trial .

Details for Vanda Pharmaceuticals Inc. v. Taro Pharmaceuticals USA, Inc. (D. Del. 2015)

Date Filed Document No. Description Snippet Link To Document
2015-10-13 1 or more claims of Vanda’s U.S. Patent No. 8,586,610 (“the ’610 patent”) and Taro’s infringement of claim…c) and 1400(b). IV. THE PATENTS-IN-SUIT – U.S. PATENT NOS. 8,586,610 AND 9,138,432 …claim 1 of Vanda’s U.S. Patent No. 9,138,432 (“the ’432 patent”), which relate to the field of schizophrenia…’610 patent, or any extensions thereof. Taro will infringe one or more claims of the ’610 patent under… the ’432 patent, or any extensions thereof. Taro will infringe claim 1 of the ’432 patent under 35 U.S.C External link to document
2015-10-13 3 Notice: N/A. Date of Expiration of Patent: 11/2/2027-U.S. 8,586,610; 9/30/2025-U.S. 9,138,432. Thirty … Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) … 13 October 2015 1:15-cv-00920 830 Patent None District Court, D. Delaware External link to document
2015-10-13 4 the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 8,586,610; 9,138,432. (sec) (… 13 October 2015 1:15-cv-00920 830 Patent None District Court, D. Delaware External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Mallinckrodt
McKesson
Johnson and Johnson
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.